Results for this period
Interim period (second quarter)2023年10月1日〜2024年3月31日ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
高利益率のコロナ禍特需案件が落ち着き、既存事業のみの売上構成に戻ったことから前年同期を大きく下回った。シニアワーク事業ではワクチン接種需要の落ち着きでコールセンター派遣が減収となり、シニアケア事業では需要・エリアの拡大と看護師派遣が増収に寄与した。
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2023年10月1日〜2024年3月31日 |
| Net Sales | ¥8,359 million (YoY -12.0%) |
| Operating profit | ¥192 million (YoY -53.0%) |
| Ordinary income | ¥172 million (YoY -58.3%) |
| Profit attributable to owners of the parent | ¥82 million (YoY -68.5%) |
| Net income per share | 9.75円 |
| Equity ratio | End of the current fiscal period 39.9 / End of previous period 36.8 |
| Total assets | ¥4,912 million |
| Net assets | ¥2,118 million |
| Full-year earnings forecast | Net Sales ¥19,500 million (YoY +9.6%) / Operating profit ¥450 million (YoY -26.1%) / Ordinary income ¥450 million (YoY -25.4%) / Profit attributable to owners of the parent ¥170 million (YoY -55.1%) |
| Annual Dividend Forecast | ¥0 → ¥0(0.0%) |
| Segment revenue | ¥1,389,590 thousand (YoY -50.1%), ¥6,969,574 thousand (YoY +3.8%) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on reversal of subscription rights to shares ¥15,724 thousand / Extraordinary loss None |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for analysts and institutional investors) |
| Issued Shares at Period-End | 8,624,320 |
| Treasury Shares at Period-End | 118,600 |
| Factors Behind Changes in Business Performance | 高利益率のコロナ禍特需案件が落ち着き、既存事業のみの売上構成に戻ったことから前年同期を大きく下回った。シニアワーク事業ではワクチン接種需要の落ち着きでコールセンター派遣が減収となり、シニアケア事業では需要・エリアの拡大と看護師派遣が増収に寄与した。 |
Items this document does not state (14)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.売上面・利益面に大きく寄与していた高利益率のコロナ禍特需案件が落ち着き、既存事業のみの売上構成に戻ったため。シニアワーク事業ではワクチン接種需要の落ち着きによりコールセンター派遣が大きく落ち込んだ一方、シニアケア事業では看護師派遣が売上高・利益に貢献した。